- Home
- PRTA vs ONDS Comparison
PRTA vs ONDS Comparison
Compare PRTA & ONDS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRTA
- ONDS
- Stock Information
- Founded
- PRTA 2012
- ONDS 2014
- Country
- PRTA Ireland
- ONDS United States
- Employees
- PRTA N/A
- ONDS N/A
- Industry
- PRTA Biotechnology: Pharmaceutical Preparations
- ONDS Telecommunications Equipment
- Sector
- PRTA Health Care
- ONDS Telecommunications
- Exchange
- PRTA Nasdaq
- ONDS Nasdaq
- Market Cap
- PRTA 472.1M
- ONDS 1.4B
- IPO Year
- PRTA N/A
- ONDS N/A
- Fundamental
- Price
- PRTA $8.20
- ONDS $5.86
- Analyst Decision
- PRTA Buy
- ONDS Strong Buy
- Analyst Count
- PRTA 10
- ONDS 3
- Target Price
- PRTA $14.86
- ONDS $4.67
- AVG Volume (30 Days)
- PRTA 1.2M
- ONDS 49.3M
- Earning Date
- PRTA 08-04-2025
- ONDS 08-12-2025
- Dividend Yield
- PRTA N/A
- ONDS N/A
- EPS Growth
- PRTA N/A
- ONDS N/A
- EPS
- PRTA N/A
- ONDS N/A
- Revenue
- PRTA $10,341,000.00
- ONDS $16,131,404.00
- Revenue This Year
- PRTA N/A
- ONDS $246.94
- Revenue Next Year
- PRTA $389.77
- ONDS $161.09
- P/E Ratio
- PRTA N/A
- ONDS N/A
- Revenue Growth
- PRTA N/A
- ONDS 75.16
- 52 Week Low
- PRTA $4.32
- ONDS $0.57
- 52 Week High
- PRTA $22.83
- ONDS $6.19
- Technical
- Relative Strength Index (RSI)
- PRTA 58.73
- ONDS 79.19
- Support Level
- PRTA $8.05
- ONDS $3.20
- Resistance Level
- PRTA $8.73
- ONDS $4.33
- Average True Range (ATR)
- PRTA 0.38
- ONDS 0.54
- MACD
- PRTA -0.05
- ONDS 0.17
- Stochastic Oscillator
- PRTA 47.62
- ONDS 89.02
About PRTA Prothena Corporation plc
Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer's disease (PRX123), Neurodegeneration (PRXPRX019), and Others.
About ONDS Ondas Holdings Inc.
Ondas Holdings Inc designs, develops, manufactures, sells, and supports FullMAX Software Defined Radio (SDR) technology in the United States, Israel, and India. The company operates in two business segments namely Ondas Networks and Ondas Autonomous Systems. The company generates maximum revenue from Ondas Autonomous Systems through the sales of the Optimus system and separately priced support, maintenance, and ancillary services related to the sale of the Optimus system.